Home  >  News
you can get e-magazine links on WhatsApp.Click here
  CDSCO issues regular market approval to Covishield and Covaxin,   January 27, 2022
  Capricor, Nippon Shinyaku ink partnership to commercialize & distribute CAP-1002 in US market to treat Duchenne muscular dystrophy,   January 27, 2022
  Sun Pharma introduces Cequa for dry eye treatment with nanomicellar technology in Canada,   January 27, 2022
  Strides’ subsidiary Universal Corporation partners with MPP to commercialize molnupiravir for global markets,   January 21, 2022
  iCubesWire bags digital marketing mandate for vHealth,   January 20, 2022
  Ascletis signs ritonavir tablet purchase agreement with Phokam Pharma,   January 19, 2022
  Merck, Ridgeback sign long-term supply agreement with UNICEF for oral antiviral Covid-19 medicine, molnupiravir,   January 19, 2022
  Avicanna inks agreement with Chilean pharma, Knop Laboratorios to supply range of cannabinoid-based API,   January 17, 2022
  Amgen, AstraZeneca announce Tezspire now available in US to treat severe asthma,   January 15, 2022
  43% pharma marketers prefer programmatic messaging platforms in India for improved physician reach,   January 14, 2022
  Amgen’s Lumykras receives European conditional marketing approval for patients with KRAS G12C-mutated advanced NSCLC,   January 11, 2022
  Regeneron, Ultragenyx collaborate to commercialize Evkeeza outside US,   January 10, 2022
  Lupin launches molnupiravir under brand name Molnulup in India to treat Covid-19,   January 07, 2022
  Biohaven, Pfizer complete collaboration transaction for commercialization of rimegepant & zavegepant outside US,   January 07, 2022
  OWP Pharma, Eversana partner to commercialize oral liquid formulations to treat neuroscience disorders,   January 06, 2022
  Dr Reddy’s to launch anti-Covid drug molnupiravir at Rs 35 per capsule,   January 05, 2022
  Brinton Pharma to introduce new anti-Covid drug molnupiravir in Indian market,   January 05, 2022
  Entod Pharma to launch generic molnupiravir under brand Molentod in India,   January 05, 2022
  Photocure begins Cysview sales, marketing & distribution operations in Canadian market,   January 04, 2022
  Beximco Pharma introduces generic version of Pfizer’s Paxlovid; the first US FDA approved oral therapy for Covid-19 treatment,   January 03, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |